A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
Background: Multiple myeloma bone disease (MMBD) constitutes a common and severe complication of multiple myeloma (MM), impacting the quality of life and survival. We evaluated the clinical value of a panel of 19 miRNAs associated with osteoporosis in MMBD. Methods: miRNAs were isolated from the pla...
Main Authors: | Aristea-Maria Papanota, Panagiotis Tsiakanikas, Christos K. Kontos, Panagiotis Malandrakis, Christine-Ivy Liacos, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3877 |
Similar Items
-
Primary intraosseous osteolytic meningioma: a case report and review of the literature
by: Sae Min Kwon, et al.
Published: (2019-07-01) -
Role of Altered Metabolic Microenvironment in Osteolytic Metastasis
by: Kerstin Tiedemann, et al.
Published: (2020-06-01) -
Efficacy of Panobinostat for the Treatment of Multiple Myeloma
by: Evangelos Eleutherakis-Papaiakovou, et al.
Published: (2020-01-01) -
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
by: Aristea-Maria Papanota, et al.
Published: (2021-02-01) -
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
by: Maria Gavriatopoulou, et al.
Published: (2020-06-01)